Alexandre Orthwein
Overview
Alexandre Orthwein, MSc, PhD, is Assistant Professor in the Department of Radiation Oncology at Emory University School of Medicine in 2022.
Prior to joining Emory, Dr. Orthwein was an Assistant Professor in the Gerald Bronfman Department of Oncology at McGill University and a Principal Investigator at the Segal Cancer Centre within the Lady Davis Institute for Medical Research at the Jewish General Hospital, where he held the Canada Research Chair in genome stability and hematological malignancies.
Education
Dr. Orthwein obtained his MSC and PhD from the Department of Microbiology and Immunology at the University of Montreal. There, he developed a strong interest in B-cell biology and hematological malignancies by studying a critical mutagenic enzyme called Activation Induced Deaminase in the laboratory of Dr. Javier M. Di Noia at the IRCM in Montreal, Canada.
He subsequently joined the laboratory of Dr. Daniel Durocher at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada for his postdoctoral training. There, he investigated the interplay between the cell cycle and the signaling/repair of DNA double-strand breaks, the most cytotoxic DNA lesions. In 2014, he became the recipient of the Young Canadian Cell Biologist of the Year awarded by the Canadian Society for Molecular Biosciences.
Research
As cancer biologist and molecular immunologist, Dr. Orthwein is primarily interested in understanding:
(i) how DNA repair pathways are regulated in different physiological contexts, including antibody diversification during B-cell development;
(ii) how their dysregulation can lead to different pathologies, such as cancer and immunodeficiency syndromes;
(iii) how these pathways influence the response to radio- and chemotherapies and the risk of relapse/resistance, particularly for hematological cancers.
His research team uses cutting-edge technologies including genome editing technologies, proteomics and single-cell transcriptomic approaches to tackle these complex and significant knowledge gaps.
Academic Appointment
- Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine
Education
Degrees
- PhD from University of Montreal
- MSc from University of Montreal
Research
Publications
-
Editorial Expression of Concern: 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.
Nature Volume: 638 Page(s): E34
02/01/2025 Authors: Fradet-Turcotte A; Canny MD; Escribano-Daz C; Orthwein A; Leung CCY; Huang H; Landry M-C; Kitevski-LeBlanc J; Noordermeer SM; Sicheri F -
Retraction Note: A mechanism for the suppression of homologous recombination in G1 cells.
Nature Volume: 638 Page(s): 844
02/01/2025 Authors: Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G -
Retraction.
Science Volume: 387 Page(s): 147
01/10/2025 Authors: Orthwein A; Fradet-Turcotte A; Noordermeer SM; Canny MD; Brun CM; Strecker J; Escribano-Diaz C; Durocher D -
The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGF Signaling.
Cancer Res Volume: 84 Page(s): 3743 - 3760
11/15/2024 Authors: Heath J; Mirabelli C; Annis MG; Sabourin V; Hebert S; Findlay S; Kim H; Witcher M; Kleinman CL; Siegel PM -
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia.
Blood Adv Volume: 8 Page(s): 5315 - 5329
10/22/2024 Authors: Jankovic M; Poon WWL; Gonzales-Losada C; Vazquez GG; Sharif-Askari B; Ding Y; Craplet-Desombre C; Ilie A; Shi J; Wang Y -
The E3 ubiquitin ligase Herc1modulates the response to nucleoside analogs in acute myeloid leukemia
BLOOD ADVANCES Volume: 8 Page(s): 5315 - 5329
10/22/2024 Authors: Jankovic M; Poon WWL; Gonzales-Losada C; Vazquez GG; Sharif-Askari B; Ding Y; Ilie A; Shi J; Wang Y; Jayavelu AK -
An E3 ubiquitin ligase localization screen uncovers DTX2 as a novel ADP-ribosylation-dependent regulator of DNA double-strand break repair.
J Biol Chem Volume: 300 Page(s): 107545
08/01/2024 Authors: Djerir B; Marois I; Dubois J-C; Findlay S; Morin T; Senoussi I; Cappadocia L; Orthwein A; Marchal A -
Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.
Res Sq
03/06/2024 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N -
The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the -Subunit Gng2.
Mol Cell Biol Volume: 44 Page(s): 1 - 16
01/01/2024 Authors: Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hbert S; Wai Lam Poon W; Aryanpour Z; Zhang T -
FIRRM cooperates with FIGNL1 to promote RAD51 disassembly during DNA repair.
Sci Adv Volume: 9 Page(s): eadf4082
08/09/2023 Authors: Pinedo-Carpio E; Dessapt J; Beneyton A; Sacre L; Brub M-A; Villot R; Lavoie EG; Coulombe Y; Blondeau A; Boulais J